The FDA just approved a new #Elrexfio dosing schedule. Patients who achieve a sustained response after a set time can now dose every 4 weeks — a shift from the previous standard of biweekly dosing. This is a meaningful step toward reduced treatment burden in #MultipleMyeloma.
2
1
0
0